Can Africa Get Close to Vaccine Independence? Here’s What It Will Take. (The New York Times)

By Stephanie Nolen
April 25, 2023

Leaders on the continent have vowed that if there is another pandemic, they won’t be shut out of the vaccine market.

Inside the labs of Afrigen Biologics and Vaccines, a Cape Town biotechnology company that has ambitions to be a major producer of new mRNA vaccines. Sydelle Willow Smith for The New York Times

Just 3 percent of all Covid-19 vaccine doses delivered in 2021 went to Africa, home to a fifth of the world’s population, according to the World Health Organization. In the vast debacle of global vaccine inequity, it was Africa that was left furthest behind as the pandemic raged, and that had the least leverage to negotiate contracts.

Read the full article in the New York Times